HARVARD BIOSCIENCE INC — Director's Dealing 2015

Apr 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2015-04-10

Reporting Person: GREEN DAVID (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-10	Common Stock	S	29336	$6.68	Disposed	865085	Direct
2015-04-13	Common Stock	S	23700	$6.56	Disposed	841385	Direct
2015-04-14	Common Stock	S	27132	$6.57	Disposed	814253	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	322124	Indirect
Common Stock	300000	Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $6.53 to $6.81. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: Reflects the transfer of 322,124 shares of common stock on March 12, 2015 from the reporting person to the David Green 2015-1 Annuity Trust.

F3: Includes (a) a deferred stock award of 19,400 restricted stock units which vest on May 30, 2015; (b) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (c) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; and (d) 789,095 shares of common stock held by the Reporting Person.

F4: This transaction was executed in multiple trades at prices ranging from $6.45 to $6.62. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: Includes (a) a deferred stock award of 19,400 restricted stock units which vest on May 30, 2015; (b) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (c) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; and (d) 765,395 shares of common stock held by the Reporting Person.

F6: This transaction was executed in multiple trades at prices ranging from $6.45 to $6.60. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: Includes (a) a deferred stock award of 19,400 restricted stock units which vest on May 30, 2015; (b) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (c) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; and (d) 738,263 shares of common stock held by the Reporting Person.